Joel Greenblatt Pacira Bio Sciences, Inc. Transaction History

Gotham Asset Management, LLC

$7.56 Billion
Q2 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 28,928 shares of PCRX stock, worth $485,990. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,928

Previous 13,541 113.63%

Holding current value

$485,990

Previous $395,000 109.37%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $392,368 - $484,844	15,387 Added 113.63%	28,928 $827,000
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $226,779 - $290,474	-8,187 Reduced 37.68%	13,541 $395,000
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $15,502 - $20,208	-589 Reduced 2.64%	21,728 $733,000
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $98,268 - $128,408	3,203 Added 16.76%	22,317 $684,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $409,420 - $538,412	-11,335 Reduced 37.23%	19,114 $765,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $1.08 Million - $1.32 Million	30,449 New	30,449 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $56,210 - $64,602	1,097 Added 27.55%	5,079 $270,000
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $130,063 - $206,222	-2,526 Reduced 38.81%	3,982 $232,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $1.08 Million - $1.38 Million	-18,066 Reduced 73.52%	6,508 $497,000
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $201,378 - $261,157	4,198 Added 20.6%	24,574 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $699,064 - $784,272	12,794 Added 168.74%	20,376 $1.14 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $17,813 - $21,066	301 Added 4.13%	7,582 $460,000
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $280,299 - $372,503	-4,726 Reduced 39.36%	7,281 $510,000
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $6,914 - $9,077	137 Added 1.15%	12,007 $718,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $90,012 - $109,116	-1,732 Reduced 12.73%	11,870 $714,000
Q2 2020 Aug 13, 2020	SELL	$30.8 - $52.47 $1.44 Million - $2.45 Million	-46,637 Reduced 77.42%	13,602 $714,000
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $897,241 - $1.6 Million	31,593 Added 110.29%	60,239 $2.02 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $808,623 - $1.04 Million	-22,270 Reduced 43.74%	28,646 $1.3 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $269,981 - $340,619	7,571 Added 17.47%	50,916 $1.94 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $1.28 Million - $1.69 Million	35,137 Added 428.08%	43,345 $1.89 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $299,345 - $346,131	8,208 New	8,208 $312,000

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

49.4M

Call Options Held

378K

Put Options Held

1.43M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $770M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account